matt weissenbach
Health06 March, 2020

Surveillance software identifies patients with modifiable C. difficile risk factors earlier 

Matt Weissenbach, Director of Clinical Operations
Watch Video
As one of the leading causes of healthcare-acquired infections and deaths, C. difficile infections are a top concern for health systems, increasing hospital length of stay by several days and inpatient costs by thousands of dollars per episode. There have been significant improvements, which leaves clinicians asking 'what more can be done?' It’s important to note that risk factors for C. difficile can be identified and evaluated as part of the direct care delivered by a clinician to a patient. Once this clinical data is documented and made available within the patient’s electronic health record, the notification of critical risk factor information can be promptly shared with the larger multidisciplinary team across clinical specialty areas, hospital locations and admission encounters. Integrating clinical surveillance software with the EHR - powered by AI technology - can play a key role to identify patients at highest risk earlier so clincians can make a bigger impact on overall outcomes.
Senior Director of Clinical Affairs
Dr. Matt Weissenbach is responsible for directing clinician efforts toward the design, development, implementation and support of Wolters Kluwer Clinical Surveillance software solutions.

Trusted real-time alerts and evidence-based guidance to ensure at-risk patients receive the right care at the right time, every time.

Sentri7's sophisticated algorithms identify at-risk patients in real-time by breaking down data silos that exist across hospitals and driving consistent clinical action. All to improve patient outcomes and hospital performance.
Back To Top